News
We recently published Jim Cramer Discusses These 10 Stocks & AI-Led Disinflation. Abbott Laboratories (NYSE:ABT) is one of ...
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
Abbott Laboratories CEO Robert Ford unpacked his company’s latest quarterly report in a Thursday interview with CNBC’s Jim ...
Abbott Laboratories (NYSE:ABT) is included among the 14 Best Pharma Dividend Stocks to Buy in 2025. Abbott Laboratories (NYSE ...
This was the stock's third consecutive day of gains.
Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...
Explore more
"Halfway through the year, we delivered high single-digit organic sales growth, double-digit EPS growth, significantly ...
Abbott Laboratories stock falls after earnings even as the company reports second-quarter sales that top expectations.
Over the past few years, Abbott Laboratories' (ABT 2.65%) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...
Abbott Laboratories closed 6.52% below its 52-week high of $141.23, which the company reached on March 4th.
Over the past few years, Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device business, but it was later able to smooth out those ...
President Trump’s made-for-TV unboxing of Abbott Laboratories’ toaster-sized testing instrument beamed into millions of households last month as he displayed the unit in the Rose Garden.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results